Can’t Win Them All: Two Merck Oncology Trials Fail

Stalwarts Lynparza And Keytruda Miss Their Mark

 
• By Alaric DeArment
  
Merck posted two back-to-back trial failures, but there are further opportunities ahead • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas